Cargando…

PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression

BACKGROUND: Lobular carcinoma in situ (LCIS) is a non-invasive breast lesion that is typically found incidentally on biopsy and is often associated with invasive lobular carcinoma (ILC). LCIS is considered by some to be a risk factor for future breast cancer rather than a true precursor lesion. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Vandna, Nowinski, Salpie, Levi, Dina, Shinomiya, Irek, Kebaier Ep Chaabouni, Narda, Gillett, Cheryl, Grigoriadis, Anita, Graham, Trevor A., Roylance, Rebecca, Simpson, Michael A., Pinder, Sarah E., Sawyer, Elinor J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240238/ https://www.ncbi.nlm.nih.gov/pubmed/28095868 http://dx.doi.org/10.1186/s13058-016-0789-y

Ejemplares similares

Genetic analysis of lobular carcinoma in situ and associated invasive lobular cancer
por: Yates, LR, et al.
Publicado: (2010)

Germline CDH1 mutations in bilateral lobular carcinoma in situ
por: Petridis, C, et al.
Publicado: (2014)

Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years
por: Petridis, Christos, et al.
Publicado: (2019)

MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours
por: Garcia-Dios, Diego A, et al.
Publicado: (2018)

Survival Outcomes in Invasive Lobular Carcinoma Compared to Oestrogen Receptor-Positive Invasive Ductal Carcinoma
por: Timbres, Jasmine, et al.
Publicado: (2021)

Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer
por: Nowinski, Salpie, et al.
Publicado: (2018)

The diagnosis and management of pre-invasive breast disease: Pathology of atypical lobular hyperplasia and lobular carcinoma in situ
por: Simpson, Peter T, et al.
Publicado: (2003)

DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?
por: Timbres, Jasmine, et al.
Publicado: (2023)

Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast
por: An, Yeji, et al.
Publicado: (2018)

Comparison of the Imaging Features of Lobular Carcinoma In Situ and Invasive Lobular Carcinoma of the Breast
Publicado: (2021)

Molecular drivers of lobular carcinoma in situ
por: Logan, Greg J., et al.
Publicado: (2015)

Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value
por: Joshi, Shalaka, et al.
Publicado: (2015)

SOX11 promotes invasive growth and ductal carcinoma in situ progression
por: Oliemuller, Erik, et al.
Publicado: (2017)

Lipogenic signalling modulates prostate cancer cell adhesion and migration via modification of Rho GTPases
por: De Piano, Mario, et al.
Publicado: (2020)

Association between PIK3CA activating mutations and outcomes in early-stage invasive lobular breast carcinoma treated with adjuvant systemic therapy
por: Ribnikar, Domen, et al.
Publicado: (2023)

Mixed ductal‐lobular carcinomas: evidence for progression from ductal to lobular morphology
por: McCart Reed, Amy E, et al.
Publicado: (2018)

The Genomic Landscape of Lobular Breast Cancer
por: McCart Reed, Amy E., et al.
Publicado: (2021)

Big Data: the challenge for small research groups in the era of cancer genomics
por: Noor, Aisyah Mohd, et al.
Publicado: (2015)

Granulomatous lobular mastitis associated with ductal carcinoma in situ of the breast
por: Oddó, David, et al.
Publicado: (2019)

Imaging Spectrum of Lobular Carcinoma In Situ and Correlation with Pathology Findings
por: Hande, Pradipta C, et al.
Publicado: (2021)

Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade
por: Lee, Jeea, et al.
Publicado: (2022)

Invasive lobular carcinoma of the breast: morphology, biomarkers and ’omics
por: Reed, Amy E McCart, et al.
Publicado: (2015)

Granulomatous lobular mastitis
por: Zhou, Fei, et al.
Publicado: (2016)

Invasive lobular carcinoma of the breast: the increasing importance of this special subtype
por: McCart Reed, Amy E., et al.
Publicado: (2021)

Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients’ survival
por: Gracio, Filipe, et al.
Publicado: (2017)

Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup – the “ATRESS” phenomenon
por: Jurrius, Patriek, et al.
Publicado: (2020)

Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions
por: Andrade, Victor P, et al.
Publicado: (2012)

Clonal relationships between lobular carcinoma in situ and other breast malignancies
por: Begg, Colin B., et al.
Publicado: (2016)

Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review
por: Wazir, Umar, et al.
Publicado: (2016)

Lobular Carcinoma In Situ Incidentally Detected by Dual-Energy Computed Tomography
por: Erdemir, Ahmet Gürkan, et al.
Publicado: (2022)

Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer
por: Lips, Esther H., et al.
Publicado: (2022)

Evolving concepts in breast lobular neoplasia and invasive lobular carcinoma, and their impact on imaging methods
por: Oliveira, Tatiane M. G., et al.
Publicado: (2014)

Comparative Immunohistochemical Analysis of Ochratoxin A Tumourigenesis in Rats and Urinary Tract Carcinoma in Humans; Mechanistic Significance of p-S6 Ribosomal Protein Expression
por: Gazinska, Patrycja, et al.
Publicado: (2012)

Invasive lobular carcinoma of the breast.
por: Hayes, D., et al.
Publicado: (1981)

Nasal Lobular Capillary Hemangioma
por: Patil, Prashant, et al.
Publicado: (2013)

Lobular capillary hemangioma of the conjunctiva
por: Suman, Suwarna, et al.
Publicado: (2022)

Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in triple negative breast cancer: the TNT trial
por: Sipos, O., et al.
Publicado: (2021)

Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene
por: Rahman, N, et al.
Publicado: (2000)

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
por: Vos, C. B., et al.
Publicado: (1997)

Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ
por: Lo, Louisa Lisa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ntqh037peu15q9upv64fk39upf